HOSPITAL-ACQUIRED PNEUMONIA ASSOCIATED WITH THE CAUSATIVE AGENT STENOTROPHOMONAS MALTOPHILIA, IN NEWBORN INFANTS

• Main Authors: M. V. Kushnareva, H. M. Marhulia, G. M. Dementyeva, E. S. Chursina, E. S. Keshishian, A. V. Semenov
• Format: Article
• Language: Russian
• Published: Ltd. “The National Academy of Pediatric Science and Innovation” 2017-06-01
• Series: Rossijskij Vestnik Perinatologii i Pediatrii
• Subjects: premature newborn children; ventilator associated pneumonia; diagnosis; clinical course; complications; stenotrophomonas maltophilia
• Online Access: https://www.ped-perinatology.ru/jour/article/view/498

Objective: to analyze the clinical course of ventilator-associated pneumonia caused by Stenotrophomonas maltophilia in infants as a high-risk group for the development of hospital acquired infection, as well as a study of the sensitivity of the pathogen to antibiotics.Eighteen infants (14 premature and 4 mature infants) with ventilator -associated pneumonia due to (Stenotrophomonas maltophilia) were monitored. The disease occurred in the majority (72%) of infants as a monoinfection, more often in severe and acute form with severe toxicosis, trophic disorders, severe respiratory failure, bilateral lung and bronchial lesions. In 33% of children, mostly premature, there was a change in the pathogen, which increased the severity and duration of the disease. Pneumonia had complications in the form of sepsis (6%) and bronchopulmonary dysplasia (28%). Most Stenotrophomonas maltophilia retained sensitivity to ticarcillin + clavulanate, ciprofloxacin, chloramphenicol and co-trimoxazol.